ANGO Financial Facts

Interest expense: -917K
Cost of sales: 42.56M
See Full Income Statement

OTHER ASSETS: 5.59M
Accounts payable: 25.51M
See Full Balance Sheet

AngioDynamics (ANGO) Earnings

  |   Expand Research on ANGO
Next EPS Date 7/11/14 *Est. EPS Growth Rate +77.8% *Last Qtr.
Average EPS % Beat Rate +56.9% Revenue Growth Rate +70.9% *Last Qtr.
Average % Move 1-Wk after EPS -1.6% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
1/9/14 Q214 $0.14$0.07 +$0.07$88.6M$87.54M N/A -21.1% Details
1/3/13 Q213 $0.10$0.09 +$0.01$87M$87.4M = +24.8% Details
4/9/14 Q314 $0.16$0.09 +$0.07$88.2M$86.85M N/A -10.5% Details
7/11/13 Q413 $0.07$0.06 +$0.01$90M$86.43M N/A +14.8% Details
10/8/12 Q113 $0.10$0.09 +$0.01$83.4M$84.35M = +10.1% Details
10/10/13 Q114 $0.04$0.03 +$0.01$83.6M$82.54M N/A -2% Details
4/8/13 Q313 $0.05$0.05 $0.00$81.6M$81.7M = +32.9% Details
7/14/11 Q411 -$0.03$0.10 -$0.13$56.4M$56.96M = -0.9% Details